Core Viewpoint - Health Road (02587) has seen a significant stock price increase, reflecting positive market sentiment and confidence in its business outlook [2][5]. Group 1: Stock Performance - Health Road's stock price increased by over 10% during trading, with a current price of 5.22 HKD, representing a 5.46% rise [2][5]. - The trading volume reached 158 million HKD, indicating strong investor interest [2][5]. Group 2: Shareholder Commitments - The controlling shareholder has voluntarily agreed to extend the second lock-up commitment for an additional six months until June 30, 2026, during which they will not sell or transfer any shares [2][5]. - As of the announcement date, Fengji Limited holds 296 million shares, accounting for approximately 33.71% of the company's total issued shares [2][5]. Group 3: Share Buyback Program - On January 19, 2026, Health Road announced a share buyback of 327,000 shares at a cost of 1.6211 million HKD, with prices ranging from 4.92 to 5.01 HKD per share [2][5]. - In early December 2025, the company indicated plans to utilize its buyback authorization to repurchase shares in the open market, with a total expenditure not exceeding 100 million HKD [2][5]. - The board believes that the proposed buyback reflects confidence in the company's business prospects and aims to enhance shareholder value [2][5].
健康之路盘中涨超10% 此前获控股股东进一步延长禁售期